"Our drug is the only one that fights the supposed cause of Alzheimer's"

PREMIUM

• LAURA TARDÓN

  Madrid

Updated Wednesday, 9June2021-13: 00

• Share on Facebook

• Share on Twitter

• Send by email

• US Therapy Approves First Alzheimer's Drug in Nearly Two Decades

• Research They develop a drug that reverses Alzheimer's symptoms in mice

In the midst of a pandemic that captures all the eyes and worldwide expectations, the US drug regulatory agency (FDA) surprised us this Monday with the accelerated approval of aducanumab, the "first and only drug that fights the supposed causes of Alzheimer's ".

This is how Sergio Teixera, the CEO of Biogen in Spain, defines it, the company responsible for a "historic milestone" that promises changes in the clinical course of an orphan disease from treatment.

Become Premium from € 1 the first month

Take advantage of this limited-time offer and access all web content

I want it

Are you already Premium?

Log in

Cancel whenever you want